News
LH
201.48
+1.02%
2.03
Mayar Capital Q1 2024 Letter To Partners
Seeking Alpha · 21h ago
5 Large-Cap Medical Stocks to Buy Ahead of Q1 Earnings
NASDAQ · 1d ago
Labcorp (LH) Expected to Beat Earnings Estimates: Should You Buy? (Revised)
NASDAQ · 1d ago
Laboratory Corp. of America on Track for Longest Losing Streak Since December 2018 -- Data Talk
Dow Jones · 1d ago
Why Labcorp (LH) Could Beat Earnings Estimates Again
NASDAQ · 1d ago
Labcorp (LH) to Report Q1 Earnings: What's in the Cards?
NASDAQ · 4d ago
Analysts Offer Insights on Healthcare Companies: Verastem (VSTM), Laboratory (LH) and Longboard Pharmaceuticals (LBPH)
TipRanks · 4d ago
Laboratory Corporation of America Holdings Enters Oversold Territory (LH)
NASDAQ · 4d ago
Laboratory Corporation of America Holdings (NYSE:LH) Is Due To Pay A Dividend Of $0.72
Laboratory Corporation of America Holdings will pay a dividend of $0.72 per share on the 12th of June. The company has a 1.4% dividend yield and is comfortably earning enough to cover its payments. The last annual payment of $2.88 was flat on the previous year. We don't see much growth potential for the company.
Simply Wall St · 4d ago
LABCORP: AVAILABILITY OF TEST FOR GLIAL FIBRILLARY ACIDIC PROTEIN (GFAP)
Reuters · 5d ago
Labcorp Announces First-of-Its-Kind Test for Early Indication of Neurodegenerative Diseases and Brain Injuries Using a Blood Draw
Innovative GFAP blood biomarker test expands Labcorp's portfolio of tests for diseases including Alzheimer's disease, multiple sclerosis, glioblastoma and brain injuries. The new GFAP test is the nation's first test for glial fibrillary acidic protein. GFAP is a critical blood-based biomarker for the early detection of neurodegenerative diseases and neurological injuries.
PR Newswire · 5d ago
Weekly Report: what happened at LH last week (0408-0412)?
Weekly Report · 5d ago
Labcorp's (LH) At-Home Mpox Testing Kit Gets the FDA's EUA Nod
NASDAQ · 04/12 13:10
Myriad Genetics (MYGN) Announces Favorable Research Results
NASDAQ · 04/11 14:00
Laboratory Corp Announces Upcoming Cash Dividend Payout
TipRanks · 04/11 12:52
Laboratory Corporation of America declares $0.72 dividend
Laboratory Corporation of America Holdings (LH) Stock declares $0.72/share quarterly dividend. Forward yield 1.39% Payable June 12; for shareholders of record May 28; ex-div May 24. Dividend is in line with previous.
Seeking Alpha · 04/11 12:05
Press Release: Labcorp Declares Quarterly Dividend
Labcorp Declares Quarterly Dividend of $0.72 per share of common stock. The dividend will be payable on June 12, 2024. Labcorp is a global leader of innovative and comprehensive laboratory services. The company provided support for 84% of the new drugs and therapeutic products approved in 2023.
Dow Jones · 04/11 10:59
Labcorp Declares Quarterly Dividend
Labcorp declares a cash dividend of $0.72 per share of common stock. The dividend will be payable on June 12, 2024, to stockholders of record on May 28, 2024. Labcorp is a global leader of innovative and comprehensive laboratory services.
PR Newswire · 04/11 10:59
Health Care Sector Update for 04/10/2024: MNDR, ALPN, LH
NASDAQ · 04/10 17:52
How a 1% Dividend Equals 68% Yearly Gains
NASDAQ · 04/10 13:30
More
Webull provides a variety of real-time LH stock news. You can receive the latest news about Laboratory Corp Amer Hldgs through multiple platforms. This information may help you make smarter investment decisions.
About LH
Laboratory Corporation of America Holdings provides comprehensive laboratory services that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. By leveraging its unparalleled diagnostics and drug development capabilities, the Company provides insights and accelerates innovations to improve health and improve lives. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The Biopharma Laboratory Services segment consists of early development research laboratories and central laboratory services. The Company serves clients in more than 100 countries.